HNO Donor

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Cardiac FailureHeart FailureReduced Ventricular Ejection Fraction

Phase 2

Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure

CompletedNCT03016325

Bristol-Myers SquibbHeart Failure

Start: 2017-01-13End: 2019-11-12Updated: 2021-01-06

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

CompletedNCT03357731

Bristol-Myers SquibbCardiac Failure, Heart Failure, Reduced Ventricular Ejection Fraction

Start: 2017-11-30End: 2019-05-10Updated: 2020-07-27

Related Papers

Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.

2020-11-2519 citations